The Hepatitis C Treatment Information Project received an advance notification from BC’s Ministry of Health that Holkira Pak (generic name: ombitasvir/paritaprevir/ritonavir and dasabuvir) will soon be considered for PharmaCare coverage. The tentative dates for input into this process are from Wednesday, April 22nd, to Wednesday, May 20th.
If you are a BC resident and answer yes to any of the following questions for Holkira Pak, you can give your input:
- Do you have hep C?
- Are you a caregiver to someone who has hep C?
- Does your patient group represent patients who have hep C AND have you registered with PharmaCare to give input? (Learn more about registering your organization).
Please note that PharmaCare’s questionnaire for Holkira Pak may not be available for another couple of weeks.